N-Tosyl-L-phenylalanyl chloromethyl ketone (TPCK), a chymotrypsin-like serine protease inhibitor, affected apoptosis in human monocytic THP.1 cells differently dependent on both the concentration used and the apoptotic stimulus. TPCK (50 ± 75 mM) induced both biochemical and ultrastructural changes characteristic of apoptosis, including proteolysis of poly (ADP-ribose) polymerase (PARP) and lamins together with formation of large kilobase pair fragments of DNA, particularly of 30 ± 50 and 200 ± 300 kilobase pairs in length but without internucleosomal cleavage of DNA. The induction of apoptosis by TPCK also involved the processing of CPP32 and Mch 3 to their catalytically active subunits. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.FMK), an ICE-like protease inhibitor, completely prevented all the biochemical and morphological changes induced by TPCK demonstrating the involvement of ICE-like proteases in the execution phase of apoptosis. Lower concentrations of TPCK (5 ± 20 mM) prevented internucleosomal cleavage of DNA induced by other apoptotic stimuli. TPCK (10 mM) inhibited cell death induced by etoposide but potentiated that induced by cycloheximide demonstrating that it differentially affected apoptosis in THP.1 cells dependent on the stimulus used. These results are consistent with at least three distinct TPCK targets, one being important for cell survival, the second in facilitating internucleosomal cleavage of DNA and the third in the modulation of apoptosis induced by different apoptotic stimuli.
Introduction
Apoptosis is a physiological form of cell death important in the control of cell populations and conserved from Caenorhabditis elegans to mammals (Arends and Wyllie, 1991; Ellis et al, 1991; Vaux, 1993) . Abnormalities in this cell death programme may be important in several human diseases including cancer, autoimmune diseases and certain neurodegenerative disorders (Arends and Wyllie, 1991; Thompson, 1995; Vaux, 1993) . Several features of the cell death programme are highly conserved (Ellis et al, 1991) . Ced-3, one of the genes required for cells to die by apoptosis in C. elegans, encodes a protein, with sequence homology to the mammalian cysteine protease, interleukin1b converting enzyme (ICE) (Yuan et al, 1993) . In addition to ICE, nine related proteases have currently been identified including Nedd-2/Ich-1 (Kumar et al, 1994; Wang et al, 1994) , CPP32/Apopain/Yama (Fernandes-Alnemri et al, 1994; Nicholson et al, 1995; Tewari et al, 1995) , Mch2 (Fernandes-Alnemri et al, 1995a) , Mch3/ICE-LAP3/CMH-1 (Duan et al, 1996a; Fernandes-Alnemri et al, 1995b) , Lippke et al, 1996) , ICE-LAP6/Mch 6 (Duan et al, 1996b; Srinivasula et al, 1996) , TX/ICErel II/Ich2 (Faucheau et al, 1995; Munday et al, 1995; Kamens et al, 1995) , ICEre1III MACH/FLICE/Mch 5 (Boldin et al, 1996; Muzio et al, 1996; Fernandes-Alnemri et al, 1996) and Mch 4 . Overexpression of any of these proteases results in cell death. As thymocytes and macrophages from ICE-deficient mice undergo apoptosis normally, except possibly for Fas-induced apoptosis, other ICE homologue(s) may be important in apoptosis (Kuida et al, 1995; Li et al, 1995) , although it is not possible to exclude functional redundancy in the system. The fact that more than one member of the ICE family may be expressed in the same cells (Wang et al, 1994) raises the possibility that these proteases may cooperate to regulate apoptosis.
Apoptosis can be induced by withdrawal of growth factors or by exposure to diverse stimuli including chemicals, radiation and viruses (Arends and Wyllie, 1991; Cohen et al, 1992a; Raff, 1992) . It was initially recognized by distinct morphological changes, including cell shrinkage, nuclear condensation and fragmentation (Arends and Wyllie, 1991) . Biochemically, internucleosomal cleavage of DNA is the characteristic most commonly associated with apoptosis (Wyllie, 1980) . Our studies and others suggest that DNA is initially cleaved into large kilobase pair fragments (200 ± 300 and 30 ± 50 kbp in length) and that these give rise to the nucleosomal fragments (Brown et al, 1993; Cohen et al, 1994; Oberhammer et al, 1993) . During apoptosis a number of proteins including histones, lamins, DNA topoisomerase I and II, poly (ADP-ribose) polymerase (PARP), U1 small ribonucleoprotein and DNA-dependent protein kinase are degraded (Casciola-Rosen et al, 1994 Kaufmann, 1989; Kaufmann et al, 1993) . Whilst ICE-like proteases are responsible for cleavage of some of these substrates, such as PARP, other proteases are also involved. Introduction of exogenous proteases into cells induces morphological and biochemical changes characteristic of apoptosis (Williams and Henkart, 1994) and various protease inhibitors block apoptosis in different cell types (Bruno et al, 1992; Chow et al, 1995; Ghibelli et al, 1995; Kaufmann et al, 1993; Sarin et al, 1993; Squier et al, 1994; Suffys et al, 1988; Zhivotovsky et al, 1995) . Much interest has focused on ICE due to its structural similarity to ced-3 (Yuan et al, 1993) . Although ICElike proteases have been implicated in the execution of apoptosis, the mechanism regulating the activity of these proteases is poorly understood. All known ICE-like proteases are expressed as inactive proforms which require cleavage at specific Asp residues to yield two subunits which combine to form the active protease (reviewed in Thornberry and Molineaux, 1995) . Although some of these may autoprocess , CPP32 can be activated by the serine protease, granzyme B (Darmon et al, 1995) . Thus CPP32 may be activated by another ICE-like protease and/or a serine protease with specificity for Asp in the P1 position.
Recently we demonstrated that apoptosis in THP.1 cells was inhibited by an ICE-like protease inhibitor, benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.FMK), which suggested that an ICE-like protease was a common mediator of apoptosis (Zhu et al, 1995) . In these cells, N-tosyl-L-lysinyl chloromethyl ketone (TLCK) potentiated apoptosis induced by several stimuli whereas it inhibited apoptosis in thymocytes (Fearnhead et al, 1995a; Zhu et al, 1995) , suggesting that a TLCK inhibitable protease may be a regulator of apoptosis. ICE and ICE-related proteases have an unusual requirement for aspartic acid in the P1 position (Thornberry et al., 1992; Thornberry and Molineaux, 1995) . TLCK requires a basic amino acid in the P1 position whereas the chymotrysin-like serine protease inhibitor used in this study, N-tosyl-L-phenylalanyl chloromethyl ketone (TPCK), requires an aromatic amino acid in the P1 position (Powers and Harper, 1986) . Thus in this study, we have investigated the ability of TPCK to modulate apoptosis in THP.1 cells, in order to investigate the possible relationship between chymotrypsin-like serine proteases and ICE-like proteases in the regulation of apoptosis.
Results

TPCK induces apoptosis assessed by¯ow cytometry
Incubation of THP.1 cells with TPCK, for 4 h caused a concentration-dependent induction of apoptosis (Table 1) , as assessed by flow cytometry. TPCK (50 ± 75 mM) induced apoptosis whereas lower concentrations (12.5 ± 25 mM) did not. Z-VAD.FMK, an inhibitor of ICE-like proteases, inhibited TPCK-induced apoptosis (Table 1) supporting the involvement of ICE-like proteases in the induction of apoptosis. When treated cells were examined by fluorescence microscopy, an increase in the number of cells with high Hoechst 33342 blue staining together with condensed nuclei was apparent compared with control cells (data not shown).
TPCK induces an intermediate apoptotic morphology
As TPCK has been described as an inhibitor of apoptosis in several cellular systems (Ghibelli et al, 1995; Suffys et al, 1988; Ruggiero et al, 1987; Neamati et al, 1995; Weaver et al, 1993) , we examined the ultrastructure of these cells in order to see if they were apoptotic. Untreated THP.1 cells were large (12 ± 16 mm) and irregular in outline with many irregular microvilli and a multi-lobed nucleus ( Figure 1A ). The diffuse perinuclear and perinucleolar heterochromatin was weakly differentiated from the euchromatin but the nucleous was clearly visible in most sections. TPCK (2 ± 6 mM), which did not induce apoptosis, had no detectable effect on the ultrastructure of THP.1 cells (data not shown). However TPCK (50 ± 75 mM) resulted in cytoplasmic condensation accompanied by pronounced dilation of the endoplasmic reticulum, the resulting vacuoles showed signs of fusion with the cell membrane, usually at one pole of the cell ( Figure 1B and D). The membrane of these cells was largely devoid of microvilli and the cytoplasm contained small (0.5 ± 1.5 mm diam.) accumulations of fine granular material. Partial nucleolar disintegration was indicated by the dispersal of the dense fibrillar component which, like numerous small clumps of partially condensed chromatin, was distributed throughout the nucleoplasm ( Figure 1B ). This ultrastructure was compared with that of apoptotic THP.1 cells, obtained following treatment with cycloheximide and TLCK (Zhu et al, 1995) , which exhibited the characteristic features of apoptosis including cell shrinkage with loss of microvilli, chromatin condensation and margination ( Figure 1C ). The degree of chromatin condensation in the cells treated with TPCK ( Figure  1B and D) was intermediate between control cells ( Figure 1A ) and apoptotic cells ( Figure 1C ). Z-VAD.FMK completely inhibited TPCK-induced apoptosis as assessed by electron microscopy ( Figure 1E ) supporting the involvement of an ICElike protease(s) in the development of the ultrastructural changes of apoptosis.
TPCK induces formation of large kilobase pair fragments of DNA TPCK caused a concentration-dependent induction of large kilobase pair DNA fragments ranging from 30 ± 50, 200 ± 300 and 700 kbp (Figure 2 ). No fragments were observed at low concentrations of TPCK (25 mM), whereas they were clearly seen at higher concentrations (50 ± 75 mM) ( Figure 2 ). These higher concentrations did not induce internucleosomal cleavage of DNA (data not shown). Thus formation of large kilobase pair fragments of DNA was observed at concentrations of TPCK (50 ± 75 mM), which induced changes detected by both flow cytometry (Table 1) 
TPCK induces proteolysis of PARP and lamins
To study further the biochemical features of apoptosis associated with the intermediate apoptotic morphology induced by TPCK ( Figure 1B ), we examined the nuclear proteins PARP and lamin B 1 . Proteolysis of PARP has been considered to be an early biochemical marker of apoptosis (Kaufmann et al, 1993) . Intact PARP in control cells was present as a 116 kDa protein (Figure 3 lane 1) , in agreement with previous findings (Kaufmann et al, 1993) . Low concentrations of TPCK (25 mM), which did not induce apoptosis as assessed by flow cytometry (Table 1) (Table 1) . Proteolysis of lamins has also been described as a common feature of apoptotic cells (Ucker et al, 1992; Lazebnik et al, 1995) . Intact lamin B 1 was present as a *67 kDa protein ( TPCK induces a DEVD.AFC cleaving activity together with processing of CPP32 and Mch 3
The induction of proteolysis of PARP and lamins by TPCK suggested that its induction of apoptosis was accompanied by an activation of ICE-like proteases. We therefore measured the CPP32/Mch 3-like protease activity, using Z-DEVD.AFC as substrate, in lysates from control cells or those exposed to different apoptotic stumuli. This model substrate was chosen because the DEVD tetrapeptide sequence is identical to the site of PARP cleaved by CPP32 (Lazebnik et al, 1994; Nicholson et al, 1995) and 
TPCK inhibits internucleosomal cleavage of DNA induced by apoptotic stimuli
Our biochemical and ultrastructural data demonstrating that TPCK induced apoptosis is in marked contrast to many reports in the literature suggesting that it inhibits apoptosis (Ghibelli et al, 1995; Suffys et al, 1988; Ruggiero et al, 1987; Neamati et al, 1995 ; Weaver et al, 1993) . Many of these studies have utilised an increase in internucleosomal cleavage as a marker of apoptosis. In order to resolve these differences, we investigated the effects of TPCK on internucleosomal cleavage induced by different apoptotic stimuli. Both etoposide alone (Figure 6 lane 3) and cycloheximide in the presence of TLCK (Figure 6 lane 5) induced internucleosomal cleavage of DNA compared with control cells (Figure 6 lane 1) . These increases in internucleosomal cleavage were completely inhibited by a low concentration of TPCK (10 mM) ( Figure 6 lanes 4 and 6) . Thus, in agreement with other reports, TPCK inhibited internucleosomal cleavage of DNA.
TPCK potentiates cycloheximide-induced apoptosis but inhibits etoposide-induced apoptosis
Co-incubation of THP.1 cells with TLCK resulted in a marked potentiation of the induction of apoptosis by a number of stimuli including cycloheximide but resulted in the inhibition of apoptosis induced by etoposide (Zhu et al, 1995) . These results suggested that a serine protease may act as a regulator of both cell survival and apoptosis in THP.1 cells. In order to explore further the nature of this putative protease, we examined whether low concentrations of TPCK, which did not induce apoptosis alone, exerted similar effects. THP.1 cells were incubated with cycloheximide (25 mM) or etoposide (25 mM) either alone or in the presence of TPCK (5 mM) or TLCK (100 mM). Both TPCK and TLCK caused a potentiation of cycloheximide-induced apoptosis but both inhibited etoposide-induced apoptosis, as assessed by flow cytometry (Figure 7 ). Similar effects were observed with a Figure 4 The induction of apoptosis was accompanied by an increase in Z-DEVD-AFC cleavage activity. THP.1 cells were incubated alone (Con) or in the presence of the indicated agents for 4 h. Lysates from these cells were assayed for Z-DEVD-AFC cleavage activity. Cychoheximide (25 mM) (CHX) induced an increase in the Z-DEVD-AFC cleavage activity, which was markedly enhanced by TLCK (100 mM). TPCK (75 mM) alone and etoposide (25 mM) (ETOP) caused a marked increase in Z-DEVD-AFC cleavage activity, while TLCK (100 mM) alone showed no effect on this activity. range of TPCK concentrations (5 ± 20 mM) (data not shown). Neither TPCK (5 mM) nor TLCK (100 mM) alone induced apoptosis ( Figure 7 ). These results suggested that a common TPCK and TLCK target may be involved in the regulation of apoptosis. As TLCK and TPCK are site-directed inhibitors of trypsin-and chymotrypsin-like proteases respectively, we investigated whether their effects on apoptosis were related to their inhibition of these proteases. Lysates from THP.1 cells were assayed, using Boc-Val-Leu-Lys-AMC and SucAla-Ala-Pro-Phe-AMC as substrates, for trypsin-and chymotrypsin-like serine proteases activity respectively (Kunugi et al, 1985; Sawada et al, 1984) . TPCK (10 mM), a concentration which modulated cycloheximide-and etoposide-induced apoptosis in a similar manner to TLCK (100 mM) did not affect these activities (Table 2) . Thus the target for TPCK and TLCK, which modulates apoptosis, is not related to these activites. In contrast, concentrations of TPCK (50 ± 75 mM), which induced apoptosis (Table 1) , caused a decrease in Boc-Val-Leu-Lys-AMC cleavage activity, but not in Suc-Ala-Ala-Pro-Phe-AMC cleaving activity ( Table 2 ), suggesting that TPCK inhibited a cellular target(s) possibly a protease(s), which is important in cell survival.
Discussion
Concentration dependent modulation of apoptosis by TPCK TPCK was initially synthesised as a specific inhibitor of chymotrypsin-like proteases (Schoellmann and Shaw, 1963) . Subsequent studies have shown that it can also affect some cysteine proteases as well as thiols in general (Shaw, 1990) . In this study, we demonstrate marked concentration dependent effects of TPCK on apoptosis in THP.1 cells.
High concentrations of TPCK induce apoptosis
TPCK (50 ± 70 mM) induced apoptosis assessed by several criteria including flow cytometry (Table 1) and TLCK (100 mM) (lanes 5 and 6). TPCK (10 mM) was added to replicates of these incubations (lanes 2, 4 and 6). THP.1 cells were treated with TLCK or TPCK for 1 h. Lysates from control cells and those treated with these inhibitors were measured for Boc-Val-Leu-Lys-AMC and Suc-Ala-Ala-Pro-Phe-AMC cleavage activities. The results are presented as mean pmol AMC/mg. protein/min+s.e.m. from at least three experiments.
PARP and lamin B 1 (Figure 3 ) and processing of CPP32 and Mch 3 ( Figure 5 ). These biochemical changes were accompanied by the induction of a distinct ultrastructure, with several features characteristic of early apoptotic changes (Kerr et al, 1987; Walker et al, 1988) , including dilation of the endoplasmic reticulum, partial nucleolar disintegration and condensation of chromatin ( Figure 1B) . Thus, TPCK alone has induced almost all the morphological and biochemical changes associated with fully apoptotic cells except for internucleosomal cleavage and the full condensation of the chromatin. These data are in good agreement with our previous studies, with thymocytes treated either with TPCK or dexamethasone in the presence of zinc, when an early apoptotic morphology was observed in the absence of internucleosomal cleavage of DNA but associated with similar sized large kilobase pair fragments of DNA (Brown et al, 1993; Cohen et al, 1992b; Fearnhead et al, 1995a) . Z-VAD.FMK inhibits apoptosis by blocking DNA fragmentation, proteolysis of PARP and processing of CPP32 in different systems including Jurkat cells, thymocytes, hepatocytes and THP.1 cells (Cain et al, 1996; Chow et al, 1995; Fearnhead et al, 1995b; Slee et al, 1996; Zhu et al, 1995) . In this study, Z-VAD.FMK inhibited all the biochemical and morphological features of apoptosis induced by TPCK including accumulation of large kilobase pair fragments, proteolysis of PARP and lamin B 1 and processing of CPP32 and Mch 3 (Figures 1 ± 5) . These results suggest that ICE-like proteases, including CPP32 and Mch 3, may be key effectors in the execution phase of TPCK-induced apoptosis. Other studes have implicated a number of different ICE-like proteases in the execution phase of apoptosis (reviewed in Kumar 1995; Martin and Green, 1995) .
The activation of a CPP32/Mch 3-like protease together with PARP degradation was observed in TPCK-induced apoptosis in intact THP.1 cells (Figures 3 and 5 ) even though TPCK inhibits the ability of bacterially expressed recombinant Mch 3 and CPP32 to cleave PARP (Fernandes-Alnemri et al, 1995b) . This difference may be due either to the concentration of TPCK (100 mM) required to inhibit recombinant CPP32 and Mch 3 (Fernandes-Alnemri et al, 1995b) or to an inability to achieve adequate concentrations of TPCK within intact cells. It is therefore unlikely that the intracellular target(s) of TPCK is CPP32 or Mch 3 but it may be a protease upstream of CPP32/Mch 3, the inhibition of which results in activation of the cell death programme. As TPCK inhibited Boc-Val-Leu-Lys-AMC cleavage activity (Table  2) , this may represent one of the TPCK targets whose inhibition results in apoptosis. The protease responsible for this cleavage activity and the mechanism whereby TPCK induces apoptosis are not known. TPCK also induces apoptosis in murine B cells and HL60 cells possibly by a decrease in c-myc expression or by inhibition of proteasome function as a result of inhibiting its chymotrypsin-like protease activity (Wu et al, 1996; Drexler, 1997) . Due to multiple functions of chloromethyl ketone groups, TPCK may affect apoptosis by different mechanisms in different cell types.
Low concentrations of TPCK inhibit internucleosomal cleavage and differentially modulate apoptosis dependent on the stimulus Low concentrations of TPCK (5 ± 10 mM) inhibited the internucleosomal cleavage of DNA induced by different apoptotic stimuli (Figure 6 ) in agreement with its effects in several different systems (Bruno et al, 1992; Chow et al, 1995; Fearnhead et al, 1995a; Hara et al, 1996; Neamati et al, 1995) . This may be related to the ability of TPCK to inhibit a 24 kDa protease, which can initiate internucleosomal cleavage of DNA (Wright et al, 1994) . Previously we have shown that TLCK potentiated apoptosis induced by some apoptotic stimuli, including cycloheximide, but inhibited apoptosis induced by etoposide (Zhu et al, 1995) . In this study, a similar effect was observed with TPCK (5 ± 10 mM) (Figure 7 ). Thus both TPCK and TLCK probably modulate apoptosis by affecting a common target. We were unable to characterise further this target using trypsin-and chymotrypsin-like substrates (Table 2) .
In summary we demonstrate, that in a single cell type, TPCK has several distinct effects on apoptosis dependent both on the apoptotic stimulus used and on the concentration of TPCK. TPCK induces apoptosis in THP.1 cells and Z-VAD.FMK inhibits this process, indicating a critical role for ICE-like proteases in the execution phase of apoptosis.
Materials and Methods
Materials
Media and sera were from Gibco (Paisley, UK). The antibody (318) to PARP was a kind gift from Dr. G. Poirier, Quebec, Canada. TPCK and TLCK were from Boehringer Mannheim (Mannheim, Germany). Z-VAD.FMK and benzyloxycarbonyl-Asp-Glu-Val-Asp-7-amino-4-trifluromethyl coumarin (Z-DEVD.AFC) were from Enzyme Systems Inc. (Dublin, CA, USA). Boc-Val-Leu-Lys-7-amino-4-methylcoumarin (BocVal-Leu-Lys-AMC), Suc-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin (Suc-Ala-Ala-Pro-Phe-AMC) were from Bachem Bioscience, Essex, U.K. Other chemicals were obtained from Sigma Chemical Company (Poole, UK).
Cell culture and electron microscopy THP.1 cells were maintained as a suspension culture as described previously (Zhu et al, 1995) . Logarithmically growing cultures of THP.1 cells were used for all experiments and they were seeded at a density of 0.5 ± 0.8610 6 /ml one day prior to the experiment. Cell pellets were fixed with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) at 48C overnight and postfixed with 1% osmium tetroxide/1.7% potassium ferrocyanide for 90 min. After fixation, cells were stained en bloc for 1 h with 2% aqueous uranyl acetate, dehydrated, and embedded in Araldite. Sections were stained with lead citrate and examined using a Zeiss 902A electron microscope (Cohen et al, 1992b) .
Quanti®cation of apoptotic cells by¯ow cytometry
Normal and apoptotic cells were separated and quantified by a flow cytometric method as originally described for thymocytes (Sun et 
DNA analysis
Internucleosomal cleavage of DNA was detected by the method of Sorenson et al (1990) . Formation of large kilobase pair fragments of DNA was detected by field inversion gel electrophoresis (Brown et al, 1993) .
Preparation of cell lysates
Lysates were prepared from control or treated THP.1 cells. Cells were lysed by using 0.25% Nonidet P-40 (50610 6 cells/100 ml) for 5 min on ice. The nuclear fraction was sedimented at 2000 g for 10 min and the supernatant was collected and stored at 7808C until assayed for protease activity. The protein concentration in the supernatant fraction (the lysate) was determined by the Bradford assay (Bio-Rad).
Measurement of protease activity
Z-DEVD.AFC, Boc-Val-Leu-Lys-AMC and Suc-Ala-Ala-Pro-Phe-AMC were used as substrates for measuring ICE-like, trypsin-like and chymotrypsin-like serine protease activities respectively (Kunugi et al, 1985; Sawada et al, 1984; Nicholson et al, 1995) . Substrate (20 mM) was added to 1.25 ml of 50 mM Tris buffer, pH 7.4, at 378C. Lysate (10 ml) was added to initiate the reaction. Fluorescence was monitored for 240 s using a Perkin Elmer fluorimeter at excitation and emission wavelengths of 380 and 460 nm for AMC, 400 and 505 nm for AFC, respectively. Standard curves were generated with AMC (0 ± 1 mM) and AFC (0 ± 1.6 mM). The protease activity was expressed as pmol AMC (or AFC)/mg. protein/min.
Western blot analysis
Cells (0.5610 6 ) were prepared for SDS ± PAGE as described (Harlow and Lane, 1988) . Proteins were resolved on a 7% SDS (PARP), 10% (lamin B 1 ) or 15% (CPP32 and Mch 3) polyacrylamide gels and transferred onto nitrocellulose. Pro-CPP32 and its catalytically active P17 subunit were detected using a rabbit polyclonal antibody directed to the p17 subunit . Pro-Mch 3 and its catalytically active p19 subunit was detected using rabbit antiserum (MacFarlane et al, 1997) . PARP was detected using rabbit antiserum (318), provided by Dr. G. Poirier (Quebec, Canada). Lamin B 1 and a proteolytic fragment were detected using a monoclonal antibody (Serotec Ltd., Oxford, UK). Detection was achieved with a secondary antibody (goat anti-rabbit IgGs) conjugated to horseradish peroxidase (diluted 1 : 2000 in the same buffer) and an ECL detection kit (Amersham Life Science, Bucks, UK).
